Live Breaking News & Updates on Protagonist Therapeutics Daily|Page 4

Stay updated with breaking news from Protagonist therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) CEO Dinesh V. Ph D. Patel Sells 25,000 Shares

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) CEO Dinesh V. Ph D. Patel Sells 25,000 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Protagonist Therapeutics Inc , Jump Financial , Jpmorgan Chase Co , Schonfeld Strategic Advisors , Algert Global , Gratus Capital , Walleye Capital , Protagonist Therapeutics , Get Free Report , Protagonist Therapeutics Daily ,

Protagonist Therapeutics (NASDAQ:PTGX) Releases Quarterly Earnings Results, Beats Expectations By $0.39 EPS

Protagonist Therapeutics (NASDAQ:PTGX) Releases Quarterly Earnings Results, Beats Expectations By $0.39 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United Kingdom General , United Kingdom , Suneel Gupta , Protagonist Therapeutics Company Profile , Blackrock Inc , Jpmorgan Chase Co , Protagonist Therapeutics Inc , Perceptive Advisors , Protagonist Therapeutics , Get Free Report , Marketwatch Earnings , Street Corp , Protagonist Therapeutics Daily ,

Protagonist Therapeutics (NASDAQ:PTGX) Releases Earnings Results, Beats Expectations By $0.39 EPS

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.39, MarketWatch Earnings reports. The business had revenue of $60.00 million during the quarter, compared to the consensus estimate of $60.00 million. Protagonist Therapeutics […] ....

Suneel Gupta , Tower Research Capital , Jpmorgan Chase Co , Protagonist Therapeutics Inc , Ensign Peak Advisors Inc , Protagonist Therapeutics Company Profile , Protagonist Therapeutics , Get Free Report , Marketwatch Earnings , Research Capital , Street Group , Peak Advisors Inc , Protagonist Therapeutics Daily , Nasdaq Ptgx ,

Connor Clark & Lunn Investment Management Ltd. Sells 23,931 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

Connor Clark & Lunn Investment Management Ltd. trimmed its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 139,494 shares of the company’s stock after selling 23,931 shares during the […] ....

Suneel Gupta , Algert Global , Exchange Commission , Jpmorgan Chase Co , Protagonist Therapeutics Company Profile , Hermes Inc , Healthcare Of Ontario Pension Plan Trust Fund , Northern Trust Corp , Connor Clark Lunn Investment Management Ltd , Protagonist Therapeutics Inc , Connor Clark , Lunn Investment Management , Protagonist Therapeutics , Free Report , Trust Corp , Ontario Pension Plan Trust Fund , Get Free Report , Protagonist Therapeutics Daily , Nasdaq Ptgx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Connor Clark & Lunn Investment Management Ltd. Sells 23,931 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

Connor Clark & Lunn Investment Management Ltd. trimmed its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 139,494 shares of the company’s stock after selling 23,931 shares during the […] ....

Suneel Gupta , Protagonist Therapeutics Inc , Connor Clark Lunn Investment Management Ltd , Northern Trust Corp , Hermes Inc , Healthcare Of Ontario Pension Plan Trust Fund , Protagonist Therapeutics Company Profile , Jpmorgan Chase Co , Algert Global , Exchange Commission , Connor Clark , Lunn Investment Management , Protagonist Therapeutics , Free Report , Trust Corp , Ontario Pension Plan Trust Fund , Get Free Report , Protagonist Therapeutics Daily ,